SB
Standard Biotools Inc
🇺🇸XNAS.LABUnited StatesHealthcare
$0.69USDdown -0.01 (-1.43%)Pre-marketDelayed1:28 PM
Price$0.69-0.01 (-1.43%)
Profile
- Healthcare
- Medical Devices
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US34385P1084
- CUSIP
- 34385P108
Company
- Employees
- 385
- Headquarters
- Boston, United States
- Website
- https://www.standardbio.com
- CEO
- Dr. Michael Egholm Ph.D.
Market
- Shares outstanding
- 392.6M
- Market cap
- $270.88M
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $270.88M
- EPS LTM
- -$0.22calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -3.10calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $84.6M-36.71%down year on year
- Net income
- -$87.38M+27.48%up year on year
- Gross margin
- 49.14%-1.74%down year on year
- Free cash flow
- -$82.58M+21.69%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.